Clinical Trial Update: Phase II Study of Systemic Screening in Pathologic Node Positive Breast Cancer [Phase 2]

View source ↗

Summary

An ongoing Phase II clinical trial evaluating systemic screening in patients with pathologic node-positive breast cancer; the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: H. Lee Moffitt Cancer Center and Research Institute | Conditions: Breast Cancer, Node-positive Breast Cancer | Phase 2 | Status: RECRUITING